US-based medical device maker Torax Medical has received approval from the FDA for the use of its next generation LINX Reflux Management System designed to prevent reflux.
The LINX System is MR conditional in magnetic resonance imaging (MRI) systems up to 1.5 Tesla (1.5T), and nearly 90% of all the MRI systems in use in the US belong to it.
Torax Medical has designed the LINX 1.5T with different grade of magnets that are resistant to damage when subjected to external magnetic fields like MRI.
LINX consists of interlinked titanium beads with magnetic cores, and the magnetic attraction between the beads boosts the existing esophageal sphincter’s barrier function which helps prevent reflux.
The device is implanted using a standard minimally invasive laparoscopic procedure, and is recommended for those suffering from GERD as defined by abnormal pH testing, and those patients who have chronic GERD symptoms despite using medical therapy.
Torax Medical president Todd Berg said: "We are pleased to make this next generation LINX device available to patients seeking relief from their reflux symptoms while broadening their access to diagnostic imaging options after treatment."
The company said that patients considering the LINX procedure should consult their healthcare provider before getting the device implanted.